Cardiac inflammation was significantly induced by NASH, as evidenced by significant increase in cardiac levels of NF-κB, IL-6 and TNF-α in the cardiotoxicity group by 39%, 92% and 80.7%, respectively, as compared to the control group (Figure 7). Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.